Introduction: Acute bilirubin encephalopathy (ABE) is associated with long-term sequelae (kernicterus). It continues to be a significant issue in our region of Nigeria, accounting for much morbidity and mortality. Herein we report the outcome of neonates with ABE seen at our centre. Methodology: We established a surveillance of children who had ABE and returned to follow-up from prospective cases of ABE (2012)(2013)(2014). ABE was diagnosed based on a bilirubin-induced neurologic dysfunction score of 1. Kernicterus was subsequently established based on a history of developmental delays, hearing impairments and abnormal physical and neurologic examinations at follow-up age 3 months. Result: Five hundred fifty-one neonates had hyperbilirubinaemia of whom 104 (18.8%) had ABE. Mean transcutaneous bilirubin using the Ingram icterometer was 18.3 mg/dl 6 SD 1.9 [(12.5-19.1), total serum bilirubin of 18.1 6 10.9] (range: 10.3-64 mg/dl). Sixty-five infants returned for follow-up (41 males and 24 females); mean age 9 months (22 days to 17 months). Most (58 of 65; 89.2%) had abnormal neurological findings and 15 (25.9%) had probable kernicterus. Conclusion: There is a critical need for a National Kernicterus Registry to document all cases of kernicterus and formulate an effective treatment and prevention policy.
I N T R O D U C T I O N
Kernicterus is a preventable, chronic, debilitating condition caused by severe neonatal hyperbilirubinaemia [1] [2] [3] [4] [5] . Kernicterus was reported to have re-emerged in parts of the world where it had been almost eradicated [6] [7] [8] [9] [10] [11] [12] [13] , largely because of decreases in vigilance. Although some reports suggest that it was not resurgence [14] , the incidence has remained high in many countries, leading to review of protocols and development of national guidelines aimed at prevention [15] [16] [17] [18] .
Severe neonatal hyperbilirubinaemia may result in acute bilirubin encephalopathy (ABE) [3, 5, 7, 12, 19, 20] , an encephalopathic state that can be subtle and reversible in its early stage, or progresses to kernicterus [1, 2, 7] . A mortality rate of 15-21.3% has been reported in Nigeria [21, 22] . Notably, these figures represent only hospitalized neonates making the V C The Author [2017] . Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com true mortality unknown especially in northern Nigeria where home birth rates are around 70% [23] . Clinically, ABE is diagnosed based on neurological findings. One useful scale to assess ABE is the bilirubin-induced neurologic dysfunction (BIND) score [24] .
The study's aim was to describe the prevalence, morbidity and mortality of infants with ABE. We describe associated risk factors for developing ABE during the neonatal period. Finally, we assessed risk of developing kernicterus at clinic follow-up.
M E T H O D S
Ethical approval was obtained from the Aminu Kano Teaching Hospital (AKTH). This is a prospective study of all infants admitted at AKTH with ABE.
Study area
Kano is one of the most populous states in Nigeria with 10 million people and a fertility rate of 8.4 children/woman [23] . The Special Care Baby Unit (SCBU) has 35 beds with >1200 yearly admissions and an associated follow-up clinic.
Study population
We included neonates with a clinical diagnosis of ABE based on BIND score of 1 [24] , discharged from the hospital and followed up in clinic, but excluded those with perinatal asphyxia or congenital malformations. A total of 2813 infants (1738 males, 1075 females) were admitted to the SCBU during the study period of whom 104 (18.9%) had ABE. All infants with ABE were given appointments to followup in clinic at 1-2 weeks and 2 months thereafter.
Definitions
Hyperbilirubinaemia was defined as clinical jaundice requiring acute medical intervention [12] . Presumed sepsis was defined as presence of clinical risk factors for sepsis and two of the following: elevated or decreased white blood cell count (>15 000 or <5000/mm 3 respectively), predominance of immature granulocytes, absolute neutropenia, band/total neutrophils 0.2 or elevated erythrocyte sedimentation rate [25] . Definite sepsis was culture-proven sepsis.
Data collection
Medical records of eligible neonates were retrieved and scrutinized when they returned for follow-up. The admission and follow-up age, sex, cause of hyperbilirubinaemia, BIND score, total serum bilirubin (TSB), packed cell volume, transcutaneous bilirubin (TcB), onset of jaundice, clinical presentation, duration of hospital stay, place of delivery, treatment, referral delay, exchange blood transfusion (EBT) and developmental milestones were noted. Neurological examination was performed at each visit. Kernicterus was diagnosed based on the clinical criteria proposed by Shapiro [26] : Infants with a history of peak TSB 20 mg/dl were considered to have certain kernicterus at the 3 month follow-up visit if they had abnormalities of muscle tone, auditory brainstem response (ABR) and magnetic resonance imaging (MRI); probable kernicterus if the child had any two of the above, one of which was abnormal muscle tone; and possible kernicterus if any one of the above three abnormalities was present. At 9-18 months, the following criteria were used: Certain kernicterus if diagnosis of probable kernicterus was made at 3 months and the child now has findings of hyperkinetic dystonia, abnormal vertical gaze and dental enamel hyperplasia; probable kernicterus if a diagnosis of possible kernicterus was made at 3 months and any two of the above three findings are observed; and possible kernicterus if there was no diagnosis of kernicterus at 3 months plus any two of the three above findings [26] .
Data analysis
Data were analysed with descriptive statistics using SPSS version 17 and presented as mean 6 standard deviation and range.
R E S U L T S

Admission
From September 2012 to September 2014, the total number of SCBU admissions was 2813 (1738 males, 1075 females). Of these, 359 neonates died (12.7%). Five hundred fifty-one (10.6%) admissions were because of jaundice/hyperbilirubinaemia of whom 104 (18.9%) had ABE (3.7% of all admissions) and 33 died, giving a case fatality rate for ABE of 32% (33 of 104). Mortality was attributed to neonatal hyperbilirubinaemia in 9% (33 of 359). Mean hospital stay was 7.2 days (65.7, 8 h to 27 days). All infants with ABE had EBT, 90 (86.5%) were double volume and 14 (13.5%) were single volume. Admission TSB levels were only available in 34 cases (52.3%). Admission age and weight and place of delivery were noted (Table 1) . Only three infants had ABR and none had an MRI because of cost and lack of availability of these studies.
Follow-up
Of the 104 neonates with ABE, 71 (68.2%) survived and were discharged. Subsequent follow-up schedule was determined by infant/child's needs with variable intervals for return visits. While all infants were advised to come to clinic at 2-3 weeks after nursery discharge and every 2 months there was considerable variation in age at follow-up with a significant proportion of infants lost to follow-up. Sixty-five (62.5%) neonates with ABE were seen in follow-up clinic. Mean age at surveillance was 9 months (22 days to 17 months).
Bilirubin levels
TcB was measured using the Ingram icterometer in all patients. Mean TcB at admission was 18.3, SD ¼ 1.9 (12.5-19.1 mg/dl). Mean peak TSB (available in only 34 neonates) was 18.1 mg/dl 6 10.9 [(15.7-64); Table 2 ].
Neurological findings BIND score in 10.3% was 1-3. However, most (59 of 65; 90.7%) had severe ABE, with a BIND score of 7-9. At follow-up, most (58 of 65; 89.2%) had a combination of abnormal neurological findings, the most common being neuromotor abnormalities (Table 3) . Of the 58 infants with abnormal neurological examination, two (3.4%) had a history of a TSB 20 mg/dl and abnormal muscle tone at 3 months of age and were classified as 'possible kernicterus', while 15 (25.9%) infants had a combination of dental enamel hypoplasia, hyperkinetic dystonia or abnormal gaze and 9-18 months of age and were classified as probable kernicterus. Twentyeight infants (48.3%) had hypertonia only at 9-18 months of age. Thirteen infants (22.4%) <3 months of age at follow-up (22-87 days) had head retraction but eight patients (12.3%) had normal neurological findings (Table 5) .
Possible causes of hyperbilirubinaemia
Possible causes of hyperbilirubinaemia in our children are summarized in Table 4 . The majority (34 of 65; 52.3%) had presumed sepsis, alone (n ¼ 32) or in combination with prematurity and ABO Blood Group Systems incompatibility (n ¼ 2), respectively, one had culture-proven sepsis. G6PD deficiency is historically common in our neonates; however, testing was available in only six, of whom four (66.7%) were deficient. Delay in hospital presentation was common, while exposure to known icterogens was uncommon. Prematurity, ABO incompatibility and rhesus isoimmunization were a factor in 3, 11 and 4 neonates, respectively. All rhesus-negative mothers Characteristics of patients with advanced features of kernicterus Nineteen neonates had advanced features of kernicterus. Of these, three had peak TSB levels <20 mg/ dl. One near-term infant presenting at 3 days of age had a low TSB (15.7 mg/dl).
D I S C U S S I O N
There is a high prevalence of ABE (104 cases/ 2 years) with high death rate (32%) in our SCBU, findings similar to reports from China, Egypt and India [27] [28] [29] . These contrast sharply with reports from Italy and Germany [15, 30] reporting 16 cases/ 10 years and 11 cases/2 years, respectively. The US kernicterus registry [16] documented only 90 cases of kernicterus over a decade, with another US study reporting a fatality rate of 10% [14] . In keeping with other reports [31] [32] [33] , most (89.2%) of our children with ABE had persistent abnormal neurological examination at follow-up. Unlike the USA, most babies in Nigeria are delivered at home [24] and jaundice is often detected late [34] , likely accounting for our high incidence of kernicterus along with the high prevalence of G6PD deficiency [35] [36] [37] [38] . Additionally, there is limited effective phototherapy, and fewer health centres capable of performing EBT. Follow-up surveillance of babies that had ABE is an important part of the management of jaundice [18] however; this is rarely done in resource-poor settings [34] . In a study in southern Nigeria [39] , 99 cases of ABE were reported over 5 years of whom only 5% came for follow-up; of these, two children had documented motor abnormality. In contrast, in this study, about 63% of the neonates with ABE where seen in follow-up and most had abnormal neurological examinations, with only about 10% normal at followup. These children will require prolonged specialized care that is expensive, time-consuming and requires expertise often not available. Hansen also reported reversibility of neurological sign in some cases of ABE following aggressive treatment [40] , highlighting the importance of prompt identification and appropriate management.
Similar to other reports [2, 10, 13, 14] , more males were affected than females, likely explained by their higher prevalence of G6PD deficiency. Our patients with kernicterus were identified at a younger mean age (9 months), than those in a California study where mean age was 3.9 years [14] . Most of our patients had neuromotor abnormalities, while only 10% had visual impairments. In contrast, visual impairment occurred in 25% in the California report 14] . Only three of our neonates had hearing screening, all were abnormal. In high-income countries with readily available hearing screening programs, >50% of children with ABE have hearing impairments [14] . Seizures, uncommonly reported in kernicterus [41] , occurred in 3% of our patients while 10% had extrapyramidal signs and 7% had dental enamel hypoplasia. Although not accessed in our study, cognition is generally preserved in kernicterus [42] . Delays in obtaining TSB results of several hours to days led to EBT being performed based on clinical BIND and TcB estimation in up to 50% of our neonates. The TcB, while a valuable screening tool, should ideally not be used to quantify the actual TSB, especially to determine treatment like EBT. Likely, many infants with maximum bilirubin levels per the icterometer had higher and hazardous bilirubin levels. This highlights one of the major limitations of this study, because TSB was not done in almost half of our patients. Because the Ingram icterometer has a maximum value of 19.05 mg/dl, it is not possible to determine a correlation coefficient even for those infants with both values available. In contrast to other reports [2, [9] [10] [11] 41] , low TSB was observed in a significant number of our neonates with kernicterus. Possible reasons include the lack of 24/7 access to a reliable laboratory meeting Clinical Laboratory Improvement Amendment quality assurance. These observations point to the urgent need for simple and affordable TSB point-ofcare machines. The high incidence of ABE/kernicterus also points to the need for cheap effective phototherapy units in low-resource countries like Nigeria, thus improving management of neonatal hyperbilirubinaemia [43, 44] .
Suspected sepsis or sepsis in combination with prematurity or haemolytic disease including G6PD deficiency (present in at least 46% of neonates with Severe Neonatal Hyperbilirubinemia) [35, 36] , can potentiate the risk for bilirubin-induced neurotoxicity. Despite recommendations that G6PD testing be available in any country with >5% G6PD deficiency [37] , this testing is rarely performed because of both cost and availability. In addition, in our study, mothers with rhesus-negative blood type did not receive immunoglobulin before delivery despite receiving antenatal care. Routine availability of lowcost testing and treatment/counselling for G6PD deficiency and rhesus could make a substantial difference in the number of case of ABE/kernicterus [43] .
C O N C L U S I O N S Kernicterus prevalence, morbidity and mortality are unacceptably high in the population we surveyed. Urgent health education and expansion of health care services is required to address this. There is a need to follow-up children with hyperbilirubinaemia and effectively manage their disabilities in low-resource settings.
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